• Translating HSP90 Chaperone Inhibition Into Oncology Brea...

  2025-10-23

  This thought leadership article dissects the mechanistic rationale, preclinical and translational evidence, and forward-looking opportunities of HSP90 inhibition in oncology. With a focus on the synthetic geldanamycin analogue 17-AAG (Tanespimycin), we integrate recent advances in cell death biology—including the selective regulation of apoptosis and DAMP release via NINJ1—to guide translational researchers in maximizing the therapeutic and strategic potential of chaperone-targeted therapies.

• LY2886721: Precision BACE1 Inhibition Strategies in Alzhe...

  2025-10-22

  Explore the advanced role of LY2886721, a potent oral BACE1 inhibitor, in Alzheimer's disease research. This article delivers a unique, mechanistic deep dive into BACE1 enzyme inhibition and amyloid beta reduction, highlighting translational opportunities and scientific nuances not covered elsewhere.

• DAPT (GSI-IX): Unraveling γ-Secretase and Notch Pathway D...

  2025-10-21

  Explore the advanced applications of DAPT (GSI-IX), a potent γ-secretase inhibitor, in dissecting Notch and amyloid precursor protein signaling within next-generation organoid and disease models. Discover unique insights into autophagy, apoptosis, and translational research beyond current literature.

168 records 12/12 page Previous First page 上5页 1112